Europe Oncology Informatics Market 2020-2030

Europe oncology informatics market accounted for $1,199.6 million in 2019 and will grow by 5.0% annually over 2020-2030 owing to the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates. Highlighted with 37 tables and 47 figures, this 114-page report “Europe Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Country. Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Electronic Health Records (EHRs) • Population Health Management (PHM) • Clinical Decision Support System (CDSS) • Drug Discovery and Development Informatics (DDDI) • Data Analytics • Image Analytics • Other Product Types

Based on Cancer Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Colorectal Cancer • Breast Cancer • Prostate Cancer • Cervical Cancer • Other Cancers Based on Application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Medical Application • Surgical Application • Radiation Application Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pharmaceutical Companies • Life Science Companies • Contract Research Organizations (CROs) • Academic Institutes and Research Centers • Other End Users

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Europe oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Cerner Corporation Change Healthcare Elekta AB F.Hoffmann-La Roche Ltd. Hologic Inc. IBM Corporation Inspirata Inc. Koninklijke Philips N.V. Laboratory Corporation of America Holdings McKesson Corporation MIM Software, Inc. Oncology Analytics, Inc PerkinElmer, Inc. RELX Group Sirenas, LLC UnitedHealth Group, Inc Varian Medical Systems, Inc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now